Sarcopenia in Acute Care Patients: Protocol for the European Collaboration of Geriatric Surveys: Sarcopenia 9+EAMA Project
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F19%3A10400087" target="_blank" >RIV/00179906:_____/19:10400087 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/19:43919064
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=rHUVjRrHe8" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=rHUVjRrHe8</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jamda.2019.04.030" target="_blank" >10.1016/j.jamda.2019.04.030</a>
Alternative languages
Result language
angličtina
Original language name
Sarcopenia in Acute Care Patients: Protocol for the European Collaboration of Geriatric Surveys: Sarcopenia 9+EAMA Project
Original language description
Sarcopenia is a disease characterized by a progressive loss of skeletal muscle mass and strength and is related to physical impairment, disability, worse clinical outcomes, and mortality in all health care settings.1 An important fact is that it is also reversible, with tailored exercise and nutritional support.1,2 Sarcopenia prevalence varies widely depending on the criteria, measurement methods, and cut-off points used for its assessment1,2; to date, few studies addressed the issue of sarcopenia in hospitalized older patients, rendering it an under-recognized clinical entity.3-5 In 2015, the European Geriatric Medicine Society (EuGMS) founded the Special Interest Group on Sarcopenia, which aims to bridge the gaps between clinical practice and research ("Action-Research Philosophy") by promoting collaborations between international scientific societies and institutions, and launching, in 2018, the revised European consensus on the definition and diagnosis on sarcopenia (EWGSOP2).1 We aim to prospectively evaluate the prevalence and incidence of sarcopenia (as defined by the EWGSOP2 criteria) in hospitalized patients across Europe (Belgium, Denmark, Germany, Italy, the Czech Republic, Poland, Portugal, Spain, and the United Kingdom) to assess risk factors associated with its presence or incidence and to assess sarcopenia-related adverse clinical outcomes.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30227 - Geriatrics and gerontology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of the American Medical Directors Association
ISSN
1525-8610
e-ISSN
—
Volume of the periodical
20
Issue of the periodical within the volume
11
Country of publishing house
US - UNITED STATES
Number of pages
3
Pages from-to
"E1"-"E3"
UT code for WoS article
000493804900001
EID of the result in the Scopus database
2-s2.0-85074053523